PowerCell Sweden Valuation
Is PCEL.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PCEL.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate PCEL.F's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate PCEL.F's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PCEL.F?
Key metric: As PCEL.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is PCEL.F's PS Ratio? | |
|---|---|
| PS Ratio | 5.9x |
| Sales | SEK 317.72m |
| Market Cap | SEK 1.87b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 5.7x |
| Enterprise Value/EBITDA | -27.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does PCEL.F's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.2x | ||
WBX Wallbox | 0.9x | 35.4% | US$158.8m |
FCEL FuelCell Energy | 2.6x | 30.0% | US$218.0m |
ULBI Ultralife | 0.8x | 25.9% | US$129.9m |
CBAT CBAK Energy Technology | 0.4x | 21.1% | US$85.5m |
PCEL.F PowerCell Sweden | 5.9x | 20.7% | US$1.9b |
Price-To-Sales vs Peers: PCEL.F is expensive based on its Price-To-Sales Ratio (5.9x) compared to the peer average (1.2x).
Price to Sales Ratio vs Industry
How does PCEL.F's PS Ratio compare vs other companies in the US Electrical Industry?
Price-To-Sales vs Industry: PCEL.F is expensive based on its Price-To-Sales Ratio (5.9x) compared to the US Electrical industry average (2x).
Price to Sales Ratio vs Fair Ratio
What is PCEL.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 5.9x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate PCEL.F's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$3.10 | US$3.95 +27.4% | 15.4% | US$4.90 | US$3.23 | n/a | 4 |
| Nov ’25 | n/a | US$4.08 0% | 14.6% | US$5.03 | US$3.42 | n/a | 4 |
| Oct ’25 | n/a | US$4.11 0% | 15.5% | US$5.19 | US$3.52 | n/a | 4 |
| Sep ’25 | n/a | US$3.58 0% | 4.4% | US$3.73 | US$3.36 | n/a | 3 |
| Aug ’25 | n/a | US$3.58 0% | 4.4% | US$3.73 | US$3.36 | n/a | 3 |
| Jul ’25 | n/a | US$3.72 0% | 9.1% | US$4.12 | US$3.29 | n/a | 3 |
| Jun ’25 | n/a | US$3.72 0% | 9.1% | US$4.12 | US$3.29 | n/a | 3 |
| May ’25 | n/a | US$3.72 0% | 9.1% | US$4.12 | US$3.29 | n/a | 3 |
| Apr ’25 | n/a | US$4.77 0% | 26.5% | US$6.03 | US$3.50 | n/a | 2 |
| Mar ’25 | n/a | US$4.77 0% | 26.5% | US$6.03 | US$3.50 | n/a | 2 |
| Feb ’25 | n/a | US$16.93 0% | 22.9% | US$20.80 | US$13.06 | n/a | 2 |
| Jan ’25 | US$4.80 | US$16.93 +252.7% | 22.9% | US$20.80 | US$13.06 | n/a | 2 |
| Dec ’24 | n/a | US$16.93 0% | 22.9% | US$20.80 | US$13.06 | n/a | 2 |
| Nov ’24 | n/a | US$14.68 0% | 23.7% | US$19.51 | US$10.62 | n/a | 4 |
| Oct ’24 | n/a | US$14.14 0% | 26.5% | US$20.08 | US$10.28 | n/a | 5 |
| Sep ’24 | n/a | US$14.14 0% | 26.5% | US$20.08 | US$10.28 | n/a | 5 |
| Aug ’24 | US$8.50 | US$14.38 +69.2% | 26.5% | US$20.42 | US$10.45 | n/a | 5 |
| Jul ’24 | n/a | US$14.38 0% | 26.5% | US$20.42 | US$10.45 | n/a | 5 |
| Jun ’24 | n/a | US$14.38 0% | 26.5% | US$20.42 | US$10.45 | n/a | 5 |
| May ’24 | US$8.01 | US$15.93 +98.9% | 21.1% | US$20.96 | US$11.41 | n/a | 5 |
| Apr ’24 | US$10.93 | US$16.09 +47.2% | 18.0% | US$20.71 | US$13.01 | n/a | 5 |
| Mar ’24 | US$13.13 | US$16.09 +22.6% | 18.0% | US$20.71 | US$13.01 | n/a | 5 |
| Feb ’24 | US$13.59 | US$14.17 +4.3% | 20.8% | US$19.20 | US$12.05 | n/a | 4 |
| Jan ’24 | n/a | US$14.17 0% | 20.8% | US$19.20 | US$12.05 | US$4.80 | 4 |
| Dec ’23 | US$11.55 | US$14.17 +22.7% | 20.8% | US$19.20 | US$12.05 | n/a | 4 |
| Nov ’23 | US$11.24 | US$14.17 +26.1% | 20.8% | US$19.20 | US$12.05 | n/a | 4 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
NFI Group
CA$1.7b
Manufactures and sells buses in North America, the United Kingdom, rest of Europe, and the Asia Pacific.
NFYE.F
CA$10.32
7D
-1.2%
1Y
4.2%
Doman Building Materials Group
CA$842.3m
Through its subsidiaries, engages in the wholesale distribution of building materials and home renovation products in the United States and Canada.
CWXZ.F
CA$6.87
7D
-0.1%
1Y
38.3%
Iveco Group
€2.4b
Engages in the design, production, marketing, sale, servicing, and financing of trucks, commercial vehicles, buses and specialty vehicles for firefighting, defense, and other applications worldwide.
IVCG.F
€9.60
7D
-0.03%
1Y
17.6%